Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Aveo Says Cancer Treatment Showed Survival Superiority Over Approved Therapy 


Drug developer Aveo Pharmaceuticals Inc. (AVEO) reported its lead drug candidate demonstrated survival superiority over a currently approved therapy in a Phase 3 trial examining the efficacy of the drug for patients living with advanced renal cell ...Read More.​


Posted on 15-Mar-12 by Geier, Eric
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: